IL2 and cancer: To determine whether NK cells target cancer stem cells and not their differentiated counterparts, NK cells were left untreated or treated with anti-CD16 antibody and/or IL-2 for 18–24 hours to induce split anergy before they were used in cytotoxicity assays against OSCSCs and OSCCs.